A Study To Assess Pharmacodynamics, Safety And Tolerability Of PF-05221304 And PF-06865571 Co-Administered For 6 Weeks In Adults With Non-Alcoholic Fatty Liver Disease.
Clinical trial NCT03776175 · COMPLETED
Trial details
- NCT number
- NCT03776175
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-04
- Primary completion
- 2019-09-09
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.